Dr. Leena T. Rahmat is a hematologist/oncologist specializing in the management of hematologic malignancies and benign hematology. She is triple boarded in Hematology, Medical Oncology, and Internal Medicine. Dr. Rahmat received her medical degree with honors from the Royal College of Surgeons in Ireland (RCSI), a Master of Arts in Clinical Investigation from Boston University School of Medicine (BUSM). She completed a residency in Internal Medicine and a fellowship in Hematology & Oncology at the University of Massachusetts Medical School-Baystate Medical Center. She has also completed an advanced fellowship in Bone Marrow Transplantation and Hematologic Malignancies at the University of San Francisco (UCSF).
She has given international lectures and presentations on the treatment of blood cancers and is widely published in the field. Her clinical expertise includes malignant blood disorders and nonmalignant blood disorders and hematopoietic stem cell transplantation. The malignant blood disorders she focuses on include non-Hodgkin lymphoma (NHL), Hodgkin lymphoma, Waldenstrom’s macroglobulinemia/lymphoplasmacytic lymphoma (WM/LPL), chronic lymphocytic leukemia (CLL) and plasma cell dyscrasias such as multiple myeloma. Dr. Rahmat’s research interests include developing novel therapies for non-Hodgkin lymphoma, with a particular interest in predicting disease relapse, early disease interventions and the use of natural health products in the treatment of hematologic malignancies.
As a member of the Johns Hopkins Kimmel Comprehensive Cancer Center team in the Greater Washington Area, Dr. Rahmat is dedicated to the practice of precision medicine, using novel therapies including immunotherapy as medium to improve patients’ quality of life and outcomes.